S&P TSX Capped Composite...

US Dollar vs CAD

Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

Get Started

ELTX Elicio Therapeutics Inc

5.62

0.48 (9.34%)

Jan 03 2025 - Closed

Delayed by 15 minutes

Form ARS - Annual Report to Security Holders

Elicio Therapeutics (NASDAQ:ELTX)
Historical Stock Chart
From Dec 2024 to Jan 2025

Click Here for more Elicio Therapeutics Charts.

Elicio Therapeutics (NASDAQ:ELTX)
Historical Stock Chart
From Jan 2024 to Jan 2025

Click Here for more Elicio Therapeutics Charts.

Elicio Therapeutics Inc News

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 18 December 2024 (3 weeks ago) • Edgar (US Regulatory)

Form 8-K - Current report
Thursday 12 December 2024 (3 weeks ago) • Edgar (US Regulatory)

Elicio Therapeutics Presents Updated Results from ELI-002 Phase 1 AMPLIFY-201 Study at ESMO Immuno-Oncology Congress 2024
Thursday 12 December 2024 (3 weeks ago) • GlobeNewswire Inc.

Form 8-K - Current report
Tuesday 3 December 2024 (1 month ago) • Edgar (US Regulatory)

Elicio Therapeutics Announces Completion of Phase 2 AMPLIFY-7P Study Enrollment
Tuesday 3 December 2024 (1 month ago) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Monday 25 November 2024 (1 month ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Monday 25 November 2024 (1 month ago) • Edgar (US Regulatory)

Form 424B3 - Prospectus [Rule 424(b)(3)]
Friday 22 November 2024 (1 month ago) • Edgar (US Regulatory)

Form 8-K - Current report
Thursday 21 November 2024 (1 month ago) • Edgar (US Regulatory)

Form EFFECT - Notice of Effectiveness
Wednesday 20 November 2024 (1 month ago) • Edgar (US Regulatory)

Form S-3 - Registration statement under Securities Act of 1933
Wednesday 13 November 2024 (2 months ago) • Edgar (US Regulatory)

Elicio Therapeutics Reports Third Quarter 2024 Financial Results and Provides Corporate Updates
Wednesday 13 November 2024 (2 months ago) • GlobeNewswire Inc.

More Elicio Therapeutics Inc News Articles

Vontobel Financial Produ...

Vontobel Financial Produ...

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions